Association between the triglyceride-glucose index and left ventricular global longitudinal strain in patients with coronary heart disease in Jilin Province, China: a cross-sectional study

Cardiovasc Diabetol. 2023 Nov 22;22(1):321. doi: 10.1186/s12933-023-02050-9.

Abstract

Background: This study aimed to investigate the association between the triglyceride-glucose (TyG) index and left ventricular global longitudinal strain (GLS) in patients with coronary heart disease and to examine the role of left ventricular GLS in detecting early changes in cardiac function in patients with coronary heart disease in the subclinical stage.

Methods: A cross-sectional study involving 178 participants with symptomatic coronary artery disease excluding myocardial infarction or left ventricular dysfunction was conducted in Jilin Province, China. Basic clinical, biochemical, and echocardiographic data were obtained from all participants. Myocardial strain parameters were compared between patients with higher TyG index and those with lower TyG index, and the association between the gradually elevated TyG index and on subclinical cardiac function in patients with coronary heart disease was evaluated.

Results: The GLS of left ventricle was lower in the higher TyG index group than in the lower TyG index group. As the TyG index increases, the GLS progressively decreases. The results remained stable after adjusting for confounding factors.

Conclusions: A higher TyG index maybe independently associated with subclinical left ventricular dysfunction in patients with coronary heart disease.

Keywords: Cardiac function; Coronary heart disease; Myocardial strain; TyG index.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Blood Glucose
  • Coronary Artery Disease* / diagnostic imaging
  • Coronary Artery Disease* / epidemiology
  • Cross-Sectional Studies
  • Global Longitudinal Strain
  • Glucose
  • Humans
  • Risk Factors
  • Triglycerides
  • Ventricular Dysfunction, Left* / diagnostic imaging
  • Ventricular Dysfunction, Left* / epidemiology
  • Ventricular Dysfunction, Left* / etiology

Substances

  • Glucose
  • Triglycerides
  • Blood Glucose
  • Biomarkers